Generation of a uracil auxotroph strain of the probiotic veast Saccharomyces boulardii as a host for the recombinant protein production

Avicenna Journal of Medical Biotechnology

Volumn 5, Issue 1, 2013, Pages 29-34

  Hamedi, Hassan ^a   Misaghi, Ali ^a   Modarressi, Mohammad Hossein ^b   Salehi, Taghi Zahraei ^a   Khorasanizadeh, Dorsa ^c   Khalaj, Vahid ^c  

^a UNIVERSITY OF TEHRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Probiotic; Recombinant proteins; Uracil; Yeasts

Indexed keywords

ACID; FLUOROOROTIC ACID; PROBIOTIC AGENT; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; URA3 PROTEIN; URACIL; URIDINE;

ARTICLE; AUXOTROPHY; BILE; CONTROLLED STUDY; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS MUTANT; GENE INACTIVATION; GENETIC MANIPULATION; IN VITRO STUDY; MUTAGENESIS; NONHUMAN; PHENOTYPE; PLASMID; SACCHAROMYCES BOULARDII;

EID: 84873134664     PISSN: 20082835     EISSN: 20084625     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. D'Silva I. Recombinant technology and probiotics. Int J Eng Technol 2011;3(4):288-293.
2. Gaon D, Garcia H, Winter L, Rodriguez N, Quintas R, Gonzalez SN, et al. Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children. Medicina 2003;63(4):293-298. (Pubitemid 37138872)
3. Hebuterne X. Gut changes attributed to ageing: effects on intestinal microflora. Current opinion in clinical nutrition and metabolic care. Curr Opin Clin Nutr Metab Care 2003;6(1):49-54. (Pubitemid 40684617)
4. Buts JP. Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives. Digestive diseases and sciences. Dig Dis Sci 2009;54(1):15-18.
5. Riaz M, Alam S, Malik A, Ali SM. Efficacy and safety of Saccharomyces boulardii in acute childhood diarrhea: A double blind randomised controlled trial. Indian J Pediatr 2012;79(4):478-482.
6. Czerucka D, Piche T, Rampal P. Review article: yeast as probiotics - Saccharomyces boulardii. Aliment Pharmacol Ther 2007;26(6):767-778. (Pubitemid 47346716)
7. Hashimoto S, Ogura M, Aritomi K, Hoshida H, Nishizawa Y, Akada R. Isolation of auxotrophic mutants of diploid industrial yeast strains after UV mutagenesis. Appl Environ Microbiol 2005;71(1):312-319. (Pubitemid 40116283)
8. Nayak S. Biology of eukaryotic probiotics. In: Liong M (eds). Probiotics. Berlin, Heidelberg: Springer-Verlag; 2011, 29-54.
9. Pronk JT. Auxotrophic yeast strains in fundamental and applied research. Appl Environ Microbiol 2002;68(5):2095-2100. (Pubitemid 34477800)
10. Umezu K, Amaya T, Yoshimoto A, Tomita K. Purification and properties of orotidine-5'-phosphate pyrophosphorylase and orotidine-5'-phosphate decarboxylase from baker's yeast. J Biochem 1971;70(2):249-262.
11. Boeke JD, La Croute F, Fink GR. A positive selection for mutants lacking orotidine-5'-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance. Mol Gen Genet 1984;197(2):345-346.
12. Peter P. Isolation of yeast DNA. In: Evans I (eds). Yeast protocols: Methods in cell and molecular biology. Totowa: Humana Press Inc; 1996, 103-107.
13. Benatuil L, Perez JM, Belk J, Hsieh CM. An improved yeast transformation method for the generation of very large human antibody libraries. Protein Eng Des Sel 2010;23(4):155-159.
14. Van Der Aa Kuhle A, Skovgaard K, Jespersen L. In vitro screening of probiotic properties of Saccharomyces cerevisiae var. boulardii and food-borne Saccharomyces cerevisiae strains. Int J Food Microbiol 2005;101(1):29-39.
15. Sleator RD, Hill C. Patho-biotechnology: using bad bugs to do good things. Curr Opin Biotechnol 2006;17(2):211-216.
16. Alani E, Cao L, Kleckner N. A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains. Genetics 1987 Aug; 116(4):541-545.
17. Van Der Aa Kuhle A, Jespersen L. The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase II gene. Syst Appl Microbiol 2003;26(4):564-571. (Pubitemid 37486515)
18. Sharaf AN, Abosereh N A R, Abdalla SM, Mohammed H, Salim R G S. Impact of some genetic treatments on the probiotic activities of Saccharomyces boulardii. Res J Cell Mol Biol 2009;3(1):12-19.
19. Abosereh NA, H A L A Mohamed, A B A El-Chalk A. Genetic construction of potentially probiotic Saccharomyces boulardii yeast strains using intraspecific protoplast fusion. J Appl Sci 2007;3(3):209-217.